Newly discovered CRISPR enzymes could lead to low cost, simultaneous disease diagnostics for multiple diseases, such as cancer and Zika virus

Briefing

Newly discovered CRISPR enzymes could lead to low cost, simultaneous disease diagnostics for multiple diseases, such as cancer and Zika virus

May 25, 2017

Briefing

  • CRISPR Enzymes Disease Diagnosis – University of California, Berkeley researchers identified 10 new CRISPR enzymes, variants of CRISPR protein Cas13a, that cut RNA with presence of certain molecules that could be indicators of disease, making molecules light up to allow for disease detection
  • Multiple Viruses Detection – Three enzymes cut RNA at adenine, a nucleic acid, instead of uracil, which allow for simultaneous detection of two RNA molecules that indicate presence of two viruses at same time
  • Low Cost On-Site Diagnostics – Can be used to test sample of patient’s blood, saliva, or urine to diagnose multiple diseases, such as cancers and viruses like Zika and dengue fever, quickly and at low cost in remote areas

Accelerator

Sector

Healthcare/Health Sciences

Organization

University of California - Berkeley

Source

Original Publication Date

May 4, 2017

Leave a comment